Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Cardiac disorder? 129 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Cardiac disorder have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 1.0% of all adverse event reports for EPOPROSTENOL.

129
Reports of Cardiac disorder with EPOPROSTENOL
1.0%
of all EPOPROSTENOL reports
40
Deaths
121
Hospitalizations

How Dangerous Is Cardiac disorder From EPOPROSTENOL?

Of the 129 reports, 40 (31.0%) resulted in death, 121 (93.8%) required hospitalization, and 1 (0.8%) were considered life-threatening.

Is Cardiac disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 129 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Cardiac disorder?

APIXABAN (4,917) SACUBITRIL\VALSARTAN (2,442) LENALIDOMIDE (2,327) ADALIMUMAB (2,272) OXYCODONE (1,891) ROSIGLITAZONE (1,732) ACETAMINOPHEN\HYDROCODONE (1,555) ACETAMINOPHEN\OXYCODONE (1,469) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (1,388) TRAMADOL (1,233)

Which EPOPROSTENOL Alternatives Have Lower Cardiac disorder Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Cardiac disorder Reports All Drugs Causing Cardiac disorder EPOPROSTENOL Demographics